Modular’s Python-like language for low-level programming has evolved, and it’s now available to end users. Let’s take Mojo ...
The drug typically costs between $5,000 and $6,000 per cycle. President Donald Trump announced a deal on Thursday between his administration and pharmaceutical company EMD Serono to reduce the cost of ...
The Food and Drug Administration approved Novo Nordisk’s NOVO.B1.23%increase; green up pointing triangle oral GLP-1 medication to reduce the risk of major cardiovascular events in high-risk adults ...
Members of the International Maritime Organization (IMO) have voted to postpone approving a plan to curb shipping emissions, after United States President Donald Trump threatened to impose sanctions ...
The FDA approved Novo Nordisk’s oral semaglutide (Rybelsus) for cardiovascular (CV) risk reduction in adults with type 2 diabetes (T2D) who are at high CV risk, whether or not they’ve had a prior CV ...
Margaret Giles: Hi, I’m Margaret Giles from Morningstar. Many baby boomers will be coming into retirement with most of their assets in tax-deferred accounts, which require withdrawals called required ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...
After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular events (MACE), the FDA has followed suit with a MACE expansion for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results